Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Digital platform to reduce the risk of infections during surgery

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Medical Imaging Innovation Improving Diagnostic Accuracy

The rapid evolution of high-resolution sensors and intelligent algorithmic...

Medical Device Innovation and Regulatory Strategy...

A comprehensive look at how the medical device sector is navigating the complex intersection of cutting-edge technology and increasingly stringent global regulations. The industry is currently shifting toward a more data-centric approach to compliance, where clinical validation and quality assurance are integrated into the earliest stages of product development.

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

One in ten people in hospital care develops a healthcare-related infection. Together with Getinge, Semcon is developing a new digital platform to make it easier to identify where the risk of infections during surgery is greatest.  

In Sweden, infections are the most common form of injury as a result of treatment in hospitals – a problem that is also widespread globally. According to an estimate from the European Centre for Disease Prevention and Control, there are nearly 9 million cases of healthcare-related infections in European hospitals and long-term care every year.

“The digital platform we are currently developing with Getinge helps healthcare better understand a number of evidence-based risk factors. Based on data from the platform, we can develop solutions to reduce the risk of infections in surgical environments. This contributes to reduced human suffering and reduced healthcare costs”, says Johan Kristensson, Team Manager and business responsible connected products at Semcon.

Using a number of sensors in an operating theatre, the digital platform can collect different types of data, which can be displayed in real time as well as analysed afterwards. This creates a better understanding of what is happening in the operating theatre and how to make improvements to reduce healthcare-related infections.

“According to the research, many endogenous and exogenous parameters have an impact, and we want this project to help us evaluate the impact of the environment in the operating theatre. Semcon has extensive experience in both product development and software development, as well as extensive knowledge in medical technology, which makes them a good partner in this project”, says Jonas Andersson, Vice President Global Product Management in Infection Control at Getinge.

A prototype is due to be tested in an operating theatre at a hospital. The project is based on a number of feasibility studies that Semcon has conducted together with Getinge, and Semcon is contributing to the project with excellence in embedded, sensing systems and UX.

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

Medical Imaging Innovation Improving Diagnostic Accuracy

The rapid evolution of high-resolution sensors and intelligent algorithmic...

Medical Device Innovation and Regulatory Strategy Trends

A comprehensive look at how the medical device sector is navigating the complex intersection of cutting-edge technology and increasingly stringent global regulations. The industry is currently shifting toward a more data-centric approach to compliance, where clinical validation and quality assurance are integrated into the earliest stages of product development.

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Medtronic Wins FDA Clearance for MiniMed Go Smart MDI System

Medtronic has received U.S. Food and Drug Administration (FDA)...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »